CPT code 33271 denotes the subcutaneous implantation of an implantable defibrillator electrode into the heart to treat life‑threatening cardiac dysrhythmias. This operative cardiac procedure is clinically significant because it addresses ventricular arrhythmias that can lead to sudden cardiac arrest; utilization patterns and coverage policies for device implantation have material implications for clinical access and hospital resource use nationwide. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find a concise overview of the clinical context for 33271, the typical sites of service, and payer coverage considerations. The publication summarizes common billing modifiers associated with surgical and device procedures, highlights typical service line placement (cardiac electrophysiology/device implantation), and outlines where further documentation and coding attention are commonly required. The content also points to benchmark topics and policy updates relevant to device implantation claims, including prior authorization trends and medical necessity determinations. Data not available in the input is noted where applicable, and the piece is written for a national audience focused on coding accuracy, billing workflow, and payer policy implications for implantable defibrillator electrode insertion.